Data from EPG Health Media - Curated by Toby Galbraith - Last updated 18 September 2019

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Zirabev▼ (Bevacizumab)

ATC
Orphan drug
No

Updated 8 days ago

Trazimera▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 10 months ago

Kanjinti▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 1 year ago

Herzuma▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 1 year ago

Mylotarg▼ (Gemtuzumab ozogamicin)

ATC
Orphan drug
Yes

Updated 1 year ago

Mvasi▼ (Bevacizumab)

ATC
Orphan drug
No

Updated 1 year ago

Ontruzant (Trastuzumab)

ATC
Orphan drug
No

Updated 1 year ago

Rituzena (Rituximab)

ATC
Orphan drug
No

Updated 1 year ago

Blitzima▼ (Rituximab)

ATC
Orphan drug
No

Updated 1 year ago

Ritemvia (Rituximab)

ATC
Orphan drug
No

Updated 1 year ago